Insulet Stock Rallies on Revenue Boost. It's a 'Misunderstood Growth Name.'
Automated insulin technology developer Insulet posts third-quarter revenue of $432.7 million, compared with $340.8 million a year earlier.
Source: marketwatch.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Glenn Shell. Real-time updates on events, politics, business and more.